Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Diamond

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Atmospheric Chemistry and Physics|February 9, 2022
Opportunistic experiments to constrain aerosol effective radiative forcingMatthew W Christensen, Andrew Gettelman, Jan Cermak, et al.
Research Square|March 2, 2022
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2Yoshihiro Kawaoka, Ryuta Uraki, Maki Kiso, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Research Square|January 4, 2022
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamstersMichael Diamond, Peter Halfmann, Tadashi Maemura, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Atmospheric Chemistry and Physics|February 9, 2022
Opportunistic experiments to constrain aerosol effective radiative forcingMatthew W Christensen, Andrew Gettelman, Jan Cermak, et al.
Research Square|March 2, 2022
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2Yoshihiro Kawaoka, Ryuta Uraki, Maki Kiso, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Research Square|January 4, 2022
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamstersMichael Diamond, Peter Halfmann, Tadashi Maemura, et al.
Pageof 4